Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yvonne Li En Ang

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
JCO Precision Oncology|August 8, 2022
Targeting Anaplastic Lymphoma Kinase in GI Primary MalignanciesJerold Loh, Yvonne Li En Ang, Amit Jain, et al.
Experimental & Molecular Medicine|January 7, 2026
The functional imperative in high-grade gliomaLaura Shih Hui Goh, Dexter Kai Hao Thng, Yvonne Li En Ang, et al.
Molecular Cancer|February 20, 2018
Third generation EGFR TKIs: current data and future directionsChee-Seng Tan, Nesaretnam Barr Kumarakulasinghe, Yi-Qing Huang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 4, 2020
An International Real-World Analysis of the Efficacy and Safety of Lorlatinib Through Early or Expanded Access Programs in Patients With Tyrosine Kinase Inhibitor-Refractory ALK-Positive or ROS1-Positive NSCLCViola W Zhu, Yen-Ting Lin, Dong-Wan Kim, et al.
Plos One|July 26, 2024
Evaluation of ex vivo drug combination optimization platform in recurrent high grade astrocytic glioma: An interventional, non-randomized, open-label trial protocolTan Boon Toh, Dexter Kai Hao Thng, Nagarjun Bolem, et al.
BMJ Open|July 5, 2024
Protocol for a systematic review with prospective individual patient data meta-analysis in EGFR-mutant NSCLC with brain metastases to assess the effect of SRS+osimertinib compared to osimertinib alone: the STARLET CollaborationKristy P Robledo, Shilo Lefresne, Yu Yang Soon, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
JCO Precision Oncology|August 8, 2022
Targeting Anaplastic Lymphoma Kinase in GI Primary MalignanciesJerold Loh, Yvonne Li En Ang, Amit Jain, et al.
Experimental & Molecular Medicine|January 7, 2026
The functional imperative in high-grade gliomaLaura Shih Hui Goh, Dexter Kai Hao Thng, Yvonne Li En Ang, et al.
Molecular Cancer|February 20, 2018
Third generation EGFR TKIs: current data and future directionsChee-Seng Tan, Nesaretnam Barr Kumarakulasinghe, Yi-Qing Huang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 4, 2020
An International Real-World Analysis of the Efficacy and Safety of Lorlatinib Through Early or Expanded Access Programs in Patients With Tyrosine Kinase Inhibitor-Refractory ALK-Positive or ROS1-Positive NSCLCViola W Zhu, Yen-Ting Lin, Dong-Wan Kim, et al.
Plos One|July 26, 2024
Evaluation of ex vivo drug combination optimization platform in recurrent high grade astrocytic glioma: An interventional, non-randomized, open-label trial protocolTan Boon Toh, Dexter Kai Hao Thng, Nagarjun Bolem, et al.
BMJ Open|July 5, 2024
Protocol for a systematic review with prospective individual patient data meta-analysis in EGFR-mutant NSCLC with brain metastases to assess the effect of SRS+osimertinib compared to osimertinib alone: the STARLET CollaborationKristy P Robledo, Shilo Lefresne, Yu Yang Soon, et al.
Pageof 1